Gainesville, FL, United States of America

Karrune Veeraprasert Woan

This inventor holds 9 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: University of Miami, H. Lee Moffitt Cancer Center and Research Institute, Inc., University of Illinois. Active years: 2012-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karrune Veeraprasert Woan. Retrieved from https://idiyas.com/inventor/karrune-veeraprasert-woan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 3)

% Patents Active = 66.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 5.5

ph-index = 7

Forward Citations = 83(Granted Patents)

Location History:

Wellington, FL (US) (2012 - 2013)
Gainesville, FL (US) (2013 - 2019)

Company Filing History:

H. Lee Moffitt Cancer Center and Research Institute, Inc.

patents

4 out of 2,432

University of Illinois

patents

where one patent can have more than one assignee

Years Active: 2012-2019

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10227295 - Selective histone deactylase 6 inhibitors (2019-03-12),

2. 9956192 - Selective histone deactylase 6 inhibitors (2018-05-01),

3. 9751832 - Selective histone deactylase 6 inhibitors (2017-09-05),

4. 9409858 - Selective histone deactylase 6 inhibitors (2016-08-09),

5. 8771680 - Topical co-enzyme Q10 formulations and methods of use (2014-07-08),

6. 8586030 - Co-enzyme Q10 formulations and methods of use (2013-11-19),

7. 8562976 - Co-enzyme Q10 formulations and methods of use (2013-10-22),

8. 8293227 - Topical co-enzyme Q10 formulations and methods of use (2012-10-23),

9. 8147825 - Topical co-enzyme Q10 formulations and methods of use (2012-04-03),

Title: **The Innovations of Karrune Veeraprasert Woan**

Introduction

Karrune Veeraprasert Woan is a notable inventor based in Gainesville, FL, who has made significant contributions to the field of cancer research through his innovative inventions. With a total of nine patents to his name, Woan's work primarily focuses on cancer treatment, particularly through the development of selective histone deacetylase (HDAC) inhibitors.

Latest Patents

Among his latest innovations are selective histone deacetylase 6 inhibitors. These patents disclose selective HDAC inhibitors characterized by a specific Formula I. The methods for making and utilizing these inhibitors hold promise for treating various cancers, especially melanoma, thereby potentially improving the therapeutic landscape for patients suffering from this challenging disease.

Career Highlights

Karrune Veeraprasert Woan has held positions in prestigious institutions such as the University of Miami and the H. Lee Moffitt Cancer Center and Research Institute. His expertise and dedication to advancing cancer treatment highlight the impact of his work in research and development.

Collaborations

Throughout his career, Woan has collaborated with fellow professionals, including Sung Lan Hsia and Niven Rajin Narain. These partnerships have been instrumental in advancing his research projects and innovations in the field of cancer therapies.

Conclusion

Karrune Veeraprasert Woan's innovative spirit and dedication to cancer research exemplify the critical role of inventors in the development of effective treatments. With his ongoing work in selective HDAC inhibitors, he continues to contribute significantly to the fight against cancer, offering hope for improved outcomes for patients worldwide.

Profile summary based on public USPTO records.